国际免疫学杂志
國際免疫學雜誌
국제면역학잡지
INTERNATIONAL JOURNAL OF IMMUNOLOGY
2011年
1期
73-76
,共4页
徐兆珍%贾秀志%周海舟%关秀茹%韩丽%任欢
徐兆珍%賈秀誌%週海舟%關秀茹%韓麗%任歡
서조진%가수지%주해주%관수여%한려%임환
系统性红斑狼疮%狼疮性肾炎%抗核抗体系列%抗双链DNA抗体
繫統性紅斑狼瘡%狼瘡性腎炎%抗覈抗體繫列%抗雙鏈DNA抗體
계통성홍반랑창%랑창성신염%항핵항체계렬%항쌍련DNA항체
Systemic lupus erythematosus%Lupus nephritis%Antinuclear antibody series%Anti-ds DNA antibody
目的探讨抗核抗体(ANA)系列指标在狼疮性肾炎(LN)患者中的表达情况及临床意义.方法对406例系统性红斑狼疮(SLE)患者(其中LN 122例)和74例其他自身免疫病患者及120例健康体检者采用间接免疫荧光法测定ANA,应用欧蒙印迹法测定ANA系列.结果 SLE患者ANA阳性率为94.49%,其他自身免疫病组ANA阳性率为55.41%,二者相比,r=0.754,P=0.019,差异有统计学意义;SLE患者及其他自身免疫病患者与正常对照组相比,r=0.983,P=0.001,差异有统计学意义.LN组ANA系列中,8个检测项目阳性率均高于不伴肾炎的SLE组,r=0.452,P=0.036,差异有统计学意义.抗双链DNA抗体+抗Sm抗体+抗nRNP抗体同时阳性时,LN组阳性表达显著高于不伴肾炎的SLE组,r=0.601,P=0.02.当抗双链DNA抗体阳性时,LN组抗组蛋白抗体、抗核小体抗体和抗核糖体p蛋白抗体同时阳性的表达也显著高于不伴肾炎的SLE组,r=0.617,P=0.022.结论 ANA及ANA系列的联合检测可以相互补充,对提高LN的诊断率及判断预后、指导治疗等方面具有重要意义.
目的探討抗覈抗體(ANA)繫列指標在狼瘡性腎炎(LN)患者中的錶達情況及臨床意義.方法對406例繫統性紅斑狼瘡(SLE)患者(其中LN 122例)和74例其他自身免疫病患者及120例健康體檢者採用間接免疫熒光法測定ANA,應用歐矇印跡法測定ANA繫列.結果 SLE患者ANA暘性率為94.49%,其他自身免疫病組ANA暘性率為55.41%,二者相比,r=0.754,P=0.019,差異有統計學意義;SLE患者及其他自身免疫病患者與正常對照組相比,r=0.983,P=0.001,差異有統計學意義.LN組ANA繫列中,8箇檢測項目暘性率均高于不伴腎炎的SLE組,r=0.452,P=0.036,差異有統計學意義.抗雙鏈DNA抗體+抗Sm抗體+抗nRNP抗體同時暘性時,LN組暘性錶達顯著高于不伴腎炎的SLE組,r=0.601,P=0.02.噹抗雙鏈DNA抗體暘性時,LN組抗組蛋白抗體、抗覈小體抗體和抗覈糖體p蛋白抗體同時暘性的錶達也顯著高于不伴腎炎的SLE組,r=0.617,P=0.022.結論 ANA及ANA繫列的聯閤檢測可以相互補充,對提高LN的診斷率及判斷預後、指導治療等方麵具有重要意義.
목적탐토항핵항체(ANA)계렬지표재랑창성신염(LN)환자중적표체정황급림상의의.방법대406례계통성홍반랑창(SLE)환자(기중LN 122례)화74례기타자신면역병환자급120례건강체검자채용간접면역형광법측정ANA,응용구몽인적법측정ANA계렬.결과 SLE환자ANA양성솔위94.49%,기타자신면역병조ANA양성솔위55.41%,이자상비,r=0.754,P=0.019,차이유통계학의의;SLE환자급기타자신면역병환자여정상대조조상비,r=0.983,P=0.001,차이유통계학의의.LN조ANA계렬중,8개검측항목양성솔균고우불반신염적SLE조,r=0.452,P=0.036,차이유통계학의의.항쌍련DNA항체+항Sm항체+항nRNP항체동시양성시,LN조양성표체현저고우불반신염적SLE조,r=0.601,P=0.02.당항쌍련DNA항체양성시,LN조항조단백항체、항핵소체항체화항핵당체p단백항체동시양성적표체야현저고우불반신염적SLE조,r=0.617,P=0.022.결론 ANA급ANA계렬적연합검측가이상호보충,대제고LN적진단솔급판단예후、지도치료등방면구유중요의의.
Objective To investigate the expression and clinical significance of the results on antinuclear antibody(ANA) series examination in patients with lupus nephritis ( LN ). Methods ANA series were detected by EUROIMMUN blotting test in serum of 406 patients with systemic lupus erythematosus (SLE)( among them, 122 were diagnosed with lupus nephritis), 74 with other autoimmune disease (AID) and 120 health controls. Positive expression and the relative level of ANA expression were further confirmed by indirect Immunofluorescence assays. Results In serum of SLE patients, the positive rate of ANA examination were 94.49%, as compared with 55.41% in the other AID group, r = 0.754, P = 0.019. In LN group, the parallel positive rate of 8 items of ANA series was significantly higher than that in SLE with no concurrent nephritis group, r =0.452,P =0.036. Simultaneous positive rate of anti-ds DNA, anti-Sm and anti-nRNP antibodies in LN group was 20.87%, as compared with 7.06% in SLE patients with no concurrent nephritis, r = 0.601,P = 0.02). Furthermore, while anti-ds DNA antibody was positive, the parallel positive rate of anti-histone,anti- nucleosome and anti-Rib P antibodies was 21.33% versus 6.47% in LN and SLE without nephritis group,respectively, r=0.617,P=0.022. Conclusion Combined ANA and ANA series examination may better diagnose patients with LN from other SLE patients and thus be of clinical significance in prognosis and providing rational adjuvant-therapies for such patients.